Affiliation:
1. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia;
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
2. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Abstract
Histiocytic tumors are a highly heterogeneous group of diseases, with Langerhans cell histiocytosis occupying the main place among it. Despite the rare frequency of occurrence, long-term analysis of clinical, morpho-immunological and molecular-biological features has allowed the development of effective treatment protocols (especially in the pediatric cohort of patients). In addition to Langerhans cell histiocytosis, the histiocytic tumors group includes rare and casuistic variants, which include histiocytic sarcoma, Langerhans cell sarcoma, indeterminate dendritic cell tumor, interdigitating dendritic cell sarcoma, follicular dendritic cell sarcoma, and fibroblastic reticular cell tumor. The incidence of certain nosological variants is several cases per hundreds of millions of the population. Not surprisingly, the diagnostic criteria for this group of tumors need to be clarified, as do the therapeutic approaches. This review presents current data on rare histiocytic tumors, clinical features as well as morphological and immunobiological characteristics of the tumor substrate. The results of modern surgical and therapeutic treatment approaches are presented.
Publisher
Publishing House ABV Press
Reference29 articles.
1. Tang X., Gao J., Ma Z.G. et al. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020. Ann Med 2021;53(1):1537–46. DOI: 10.1080/07853890.2021.1966085.
2. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edn.). Eds.: S.H. Swerdlow, E. Campo, N.L. Harris et al. Lyon: IARC, 2017. 470 p.
3. Kommalapati A., Tella S.H., Durkin M. et al. Histiocytic sarcoma: a populationbased analysis of incidence, demographic disparities, and long-term outcomes. Blood 2018;131(2):265–8. DOI: 10.1182/blood-2017-10-812495.
4. Doronin V.A., Krivolapov Yu.A., Nechesnyuk A.V., Pivnik A.V. Histiocytic sarcoma. A clinical case and review of the literature. Klinicheskaya onkogematologiya. Fundamental’nye issledovaniya i klinicheskaya praktika = Clinical Oncohematology. Fundamental Research and Clinical Practice 2009;2(2):161–6. (In Russ.)
5. Feldman A.L., Arber D.A., Pittaluga S. et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 2008;111(12):5433–9. DOI: 10.1182/blood-2007-11-124792.